Why Bruker Stock Slumped Monday
(NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the closing bell, as investors didn't take kindly to a double miss on full-year guidance. Earlier in the trading session, Bruker dipped as much as 3.9%.
Bruker, which specializes in the supply of medical devices and scientific instruments, earned revenue of almost $861 million in its third quarter. This number was down 0.5% from the same period of 2024.
Image source: Getty Images.
Source Fool.com
Bruker Corp. Aktie
41,72 €
-2,30 %
Positive Einschätzungen für Bruker Corp. überwiegen: Mehrere Buy-, keine Sell-Einschätzungen.
Das Kursziel von 46 € für Bruker Corp. zeigt eine leichte Steigerung gegenüber dem aktuellen Kurs von 41.72 € an.
